# MTD Group completes acquisition of Ypsomed's pen needles and BGM businesses

Medical Technology and Devices (MTD) has closed the acquisition of Ypsomed's Pen Needles and Blood Glucose Monitoring Systems businesses. The deal increases MTD's pen needle production capacity to over 2.5 billion units, strengthening its position as the world's #2 player.

- Type: Acquisition
- Announced: 2024-08-02
- Where: Italy
- Status: completed
- Capacity: over 2.5 billion pen needles
- Products: pen needles, blood glucose monitoring systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ypsomed](https://endata.com/companies/9625.md) (target)
- [MTD Medical Technology and Devices](https://endata.com/companies/76653.md) (acquirer)

## Sources

- [prnewswire.co.uk](https://www.prnewswire.co.uk/news-releases/mtd-group-completes-the-acquisition-of-ypsomeds-pen-needles-and-blood-glucose-monitoring-systems-and-announces-a-significant-investment-plan-for-its-european-production-sites-302212655.html), 2024-08-02: "This acquisition marks a major step forward in MTD's mission to provide superior diabetes and obesity care solutions on a global scale."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.